Lake County-headquartered Nexus Pharmaceuticals has received FDA Approval for its innovative Tirofiban Hydrochloride Injection, designed to reduce the rate of certain cardiovascular events. This is a big milestone for the US-based, woman-led, minority-owned healthcare company that specializes in innovative processes to make difficult-to-manufacture specialty and generic injectables.
< BACK TO MAIN NEWS PAGE